Concerns the quality and delivery of mammography. Guideline statements were developed based on scientific evidence and on the basis of panel expert opinion. Covers activities before, during and after the exam, mammography personnel, referring providers and adverse consequences and other problems. Extensive bibliography, acronyms and abbreviations and glossary. 19 drawings and tables.

Mammography is an important tool for detecting breast cancer at an early stage. When coupled with appropriate treatment, early detection can reduce breast cancer mortality. At the request of Congress, the Food and Drug Administration (FDA) commissioned a study to examine the current practice of mammography and breast cancer detection, with a focus on the FDA's oversight via the Mammography Quality Standards Act (MQSA), to identify areas in need of improvement. Enacted in 1993, MQSA provides a general framework for ensuring national quality standards in facilities performing screening mammography, requires that each mammography facility be accredited and certified, and mandates that facilities will undergo annual inspections. This book recommends strategies for achieving continued progress in assuring mammography quality, including changes to MQSA regulation, as well as approaches that do not fall within the purview of MQSA. Specifically, this book provides recommendations aimed at improving mammography interpretation; revising MQSA regulations, inspections, and enforcement; ensuring an adequate workforce for breast cancer screening and diagnosis; and improving breast imaging quality beyond mammography.

Bogen er en grundlæggende lærebog om digital mammografi, hvori digital mammografi og traditionel mammografi også sammenlignes i forhold til screening, diagnoser og radiografisk billedteknik. Der er en komplet billedsamling af cases indenfor digital mammografi.

This volume (5116) of Springer’s Lecture Notes in Computer Science contains the th proceedings of the 9 International Workshop on Digital Mammography (IWDM) which was held July 20 – 23, 2008 in Tucson, AZ in the USA. The IWDM meetings traditionally bring together a diverse set of researchers (physicists, mathematicians, computer scientists, engineers), clinicians (radiologists, surgeons) and representatives of industry, who are jointly committed to developing technologies to support clinicians in the early detection and subsequent patient management of breast cancer. The IWDM conference series was initiated at a 1993 meeting of the SPIE Medical Imaging Symposium in San Jose, CA, with subsequent meetings hosted every two years at sites around the world. Previous meetings were held in York, England; Chicago, IL USA; Nijmegen, Netherlands; Toronto, Canada; Bremen, Germany; Durham, NC USA and Manchester, UK. th The 9 IWDM meeting was attended by a very international group of participants, and during the two and one-half days of scientific sessions there were 70 oral presentations, 34 posters and 3 keynote addresses. The three keynote speakers discussed some of the “hot” topics in breast imaging today. Karen Lindfors spoke on “Dedicated Breast CT: Initial Clinical Experiences. ” Elizabeth Rafferty asked the question is “Breast Tomosynthesis: Ready for Prime Time?” Finally, Martin Tornai discussed “3D Multi-Modality Molecular Breast Imaging.